Literature DB >> 20001991

Transfusion-transmitted infections in haemophilia patients.

Bukurije Zhubi1, Ymer Mekaj, Zana Baruti, Ilirijane Bunjaku, Mazllum Belegu.   

Abstract

One of the largest therapeutic problem during the continuous treatment of the patients with Hemophilia A and B, are viral infections as Hepatitis B and C, and HIV, and the other infective diseases, which can be transmitted by the transfusion of blood products. The aim of this study is to analyze the complications of the hemophiliacs in Kosovo which have been treated with fresh frozen plasma, cryoprecipitate and concentrated products of FVIII and FIX. We have tested 75 patients with hemophilia A or B and there were used enzyme immunoassay test-Elisa method for the following: anti-HCV, HBsAg, HIV and TPHA.The serological data showed that HCV infection was positive in 29 cases or 38,7%, whereas infection with HBV and HIV were present in a smaller percentage of the patients (2,7% HBV and 1,4% for HIV). HCV infection was present only in 9,5% of the cases of the age group under 18 years. Infected hemophiliacs with one or two infective agents were found in 34,7%, respectively 4%. Infection with T. pallidum was present at none of the examined patients with hemophilia. HCV infection was higher in severe forms of hemophilia B (44,4%), compared with severe form of hemophilia A (30%).Based on our results, despite the infrequent application of FVIII and FIX concentrates, and other anti hemophilic preparations used in treating hemophilia patients, the number of infected hemophiliacs with blood-transmittable infectious agents was substantially high, especially with hepatitis C virus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001991      PMCID: PMC5603681          DOI: 10.17305/bjbms.2009.2777

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  45 in total

1.  Alpha interferon therapy in Danish haemophiliac patients with chronic hepatitis C: results of a randomized controlled open label study comparing two different maintenance regimens following standard interferon-alpha-2b treatment.

Authors:  A L Laursen; E Scheibel; J Ingerslev; N C Clausen; P Wantzin; L Ostergaard; G Schou; F T Black; K Krogsgaard
Journal:  Haemophilia       Date:  1998-01       Impact factor: 4.287

2.  A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers.

Authors:  M G Rumi; E Santagostino; M Morfini; A Gringeri; G Tagariello; A Chistolini; P Pontisso; A Tagger; M Colombo; P M Mannucci
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

3.  A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers.

Authors:  F Tradati; M Colombo; P M Mannucci; M G Rumi; C De Fazio; G Gamba; N Ciavarella; A Rocino; M Morfini; A Scaraggi; E Taioli
Journal:  Blood       Date:  1998-02-15       Impact factor: 22.113

4.  Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C.

Authors:  E P Mauser-Bunschoten; M Damen; H W Reesink; G Roosendaal; R A Chamuleau; H M van den Berg
Journal:  Ann Intern Med       Date:  1996-08-15       Impact factor: 25.391

5.  Hepatitis C infection in children with haemophilia: a pilot study.

Authors:  D Posthouwer; V M Wolters; K Fischer; R H J Houwen; H M van den Berg; E P Mauser-Bunschoten
Journal:  Haemophilia       Date:  2004-11       Impact factor: 4.287

6.  Development of inhibitors in patients with haemophilia from India.

Authors:  K Ghosh; S Shetty; B Kulkarni; S Nair; A Pawar; A Khare; S Baindur; D Mohanty
Journal:  Haemophilia       Date:  2001-05       Impact factor: 4.287

Review 7.  Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia.

Authors:  J J Goedert; D L Brown; K Hoots; K E Sherman
Journal:  Haemophilia       Date:  2004-10       Impact factor: 4.287

8.  Serum hepatitis B virus DNA detects cryptic hepatitis B virus infections in multitransfused hemophilic patients.

Authors:  M G Rumi; M Colombo; R Romeo; G Colucci; A Gringeri; P M Mannucci
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

9.  An economic model of haemophilia in Mexico.

Authors:  C Martínez-Murillo; S Quintana; R Ambriz; H Benitez; A Berges; J Collazo; A Esparza; T Pompa; C Taboada; S Zavala; M R Larochelle; J D Bentkover
Journal:  Haemophilia       Date:  2004-01       Impact factor: 4.287

10.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

View more
  6 in total

Review 1.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

2.  Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis.

Authors:  Seyed Moayed Alavian; Seyed Hossein Aalaei-Andabili
Journal:  Hepat Mon       Date:  2012-04-30       Impact factor: 0.660

3.  Hepatitis C virus infection in patients with hemophilia in Isfahan, Iran.

Authors:  Mohammad Reza Yazdani; Nazila Kassaian; Behrooz Ataei; Zary Nokhodian; Peyman Adibi
Journal:  Int J Prev Med       Date:  2012-03

4.  Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland.

Authors:  Marta Kucharska; Malgorzata Inglot; Aleksandra Szymczak; Weronika Rymer; Malgorzata Zalewska; Krzysztof Malyszczak; Urszula Zaleska-Dorobisz; Malgorzata Kuliszkiewicz-Janus
Journal:  Hepat Mon       Date:  2016-07-23       Impact factor: 0.660

5.  Seroprevalence of hepatitis C, hepatitis B and HIV viruses in hemophiliacs born 1985-2010 in west Azarbaijan of Iran.

Authors:  Nasim Valizadeh; Shahin Nateghi; Mehran Noroozi; Sasan Hejazi; Fateme Aghanezhad; Afsaneh Akbarpoor Morad Ali
Journal:  Asian J Transfus Sci       Date:  2013-01

Review 6.  Hepatitis C infection in patients with hereditary bleeding disorders: epidemiology, natural history, and management.

Authors:  Nikolaos Papadopoulos; Vasiliki Argiana; Melanie Deutsch
Journal:  Ann Gastroenterol       Date:  2017-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.